Literature DB >> 23279041

In vitro antibiotic susceptibility patterns of Propionibacterium acnes isolated from acne patients: an Egyptian university hospital-based study.

N S A Abdel Fattah1, Y W Darwish.   

Abstract

BACKGROUND: Antibiotics have been used for more than 40 years against Propionibacterium acnes (P. acnes), the most common agent of acne. Antibiotic resistance to this bacterium becomes a worldwide problem in recent years. No studies are available on antibiotic susceptibility patterns of P. acnes among Egyptian acne patients.
OBJECTIVE: To determine antibiotic susceptibility patterns of P. acnes isolated from acne patients attending the Dermatology outpatient clinic of an Egyptian university hospital to the most commonly prescribed antibiotics and to determine the difference in relation to age of patients, disease duration and previous antibiotic therapy for acne.
METHODS: Cutaneous samples were obtained from pustular acne lesions on the face of 115 patients, which were cultured in anaerobic media to demonstrate the presence of P. acnes. Antibiotic susceptibility tests of isolated P. acnes were then performed to clindamycin, erythromycin, azithromycin, oxytetracycline and doxycycline by disk diffusion method.
RESULTS: Propionibacterium acnes was isolated from 98 patients. Eighty-nine isolates were susceptible to azithromycin, followed by doxycycline and oxytetracycline isolated from 82 and 72 patients respectively. Resistance of P. acnes to clindamycin was detected in 65 patients, followed by erythromycin in 48 patients. Comparing the antibiotic susceptibility patterns of P. acnes isolated from patients with and without previous antibiotic therapy for acne revealed statistically non-significant differences as regards any of the antibiotics tested except for clindamycin and erythromycin. Statistically non-significant differences existed between antibiotic susceptibility patterns of P. acnes to all tested antibiotics regarding age of patients (< or ≥ 20 years) and disease duration (< or ≥ 2 years).
CONCLUSION: Propionibacterium acnes in vitro susceptibility patterns differed among Egyptian patients to the commonly prescribed antibiotics with the highest to lowest resistance to clindamycin, erythromycin, oxytetracycline, doxycycline and azithromycin.
© 2012 The Authors. Journal of the European Academy of Dermatology and Venereology © 2012 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23279041     DOI: 10.1111/jdv.12057

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  10 in total

1.  Comparison effect of azithromycin gel 2% with clindamycin gel 1% in patients with acne.

Authors:  Fatemeh Mokhtari; Gita Faghihi; Akram Basiri; Sadaf Farhadi; Mohammadali Nilforoushzadeh; Shadi Behfar
Journal:  Adv Biomed Res       Date:  2016-04-19

Review 2.  Meeting the Challenges of Acne Treatment in Asian Patients: A Review of the Role of Dermocosmetics as Adjunctive Therapy.

Authors:  Chee Leok Goh; Nopadon Noppakun; Giuseppe Micali; Noor Zalmy Azizan; Waranya Boonchai; Yung Chan; Wai Kwong Cheong; Pin Chi Chiu; Kristiana Etnawati; Zharlah Gulmatico-Flores; Henry Foong; Raj Kubba; Purita Paz-Lao; Yin Yin Lee; Steven Loo; Farida Modi; Trong Hao Nguyen; Thi Lan Pham; Yi Hsien Shih; Irma Bernadette Sitohang; Su Ni Wong
Journal:  J Cutan Aesthet Surg       Date:  2016 Apr-Jun

3.  Comparison of the Efficacy of Azithromycin Versus Doxycycline in Acne Vulgaris: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Jung Eun Kim; A Young Park; Sung Yul Lee; Young Lip Park; Kyu Uang Whang; Hyun-Jung Kim
Journal:  Ann Dermatol       Date:  2018-06-28       Impact factor: 1.444

4.  Recurrent Lymphocytic Pleural Effusion as a Complication of Ventriculopleural Shunt Meningitis Caused by Cutibacterium Acnes.

Authors:  Abdelmohaymin A Abdalla; Ragda Ali; Mansi Oberoi; Paul Berger
Journal:  Cureus       Date:  2021-02-10

5.  Hydrogel Containing Borassus flabellifer L. Male Flower Extract for Antioxidant, Antimicrobial, and Anti-Inflammatory Activity.

Authors:  Prakairat Tunit; Phanit Thammarat; Siriporn Okonogi; Chuda Chittasupho
Journal:  Gels       Date:  2022-02-17

6.  C. acnes qPCR-Based Antibiotics Resistance Assay (ACQUIRE) Reveals Widespread Macrolide Resistance in Acne Patients and Can Eliminate Macrolide Misuse in Acne Treatment.

Authors:  Jingheng Zhang; Fang Yu; Keyun Fu; Xinyu Ma; Yi Han; Chi Ching Ali; Haonan Zhou; Yantao Xu; Tingyue Zhang; Shuntong Kang; Yiming Xu; Zhuolin Li; Jiaqi Shi; Shuai Gao; Yongyi Chen; Liyu Chen; Jianglin Zhang; Feizhou Zhu
Journal:  Front Public Health       Date:  2022-03-18

7.  Antibiotic Susceptibility of Cutibacterium acnes Strains Isolated from Israeli Acne Patients.

Authors:  Sivan Sheffer-Levi; Amit Rimon; Vanda Lerer; Tehila Shlomov; Shunit Coppenhagen-Glazer; Chani Rakov; Tamara Zeiter; Ran Nir-Paz; Ronen Hazan; Vered Molho-Pessach
Journal:  Acta Derm Venereol       Date:  2020-10-20       Impact factor: 3.875

8.  Cross-sectional Pilot Study of Antibiotic Resistance in Propionibacterium Acnes Strains in Indian Acne Patients Using 16S-RNA Polymerase Chain Reaction: A Comparison Among Treatment Modalities Including Antibiotics, Benzoyl Peroxide, and Isotretinoin.

Authors:  Kabir Sardana; Tanvi Gupta; Bipul Kumar; Hemant K Gautam; Vijay K Garg
Journal:  Indian J Dermatol       Date:  2016 Jan-Feb       Impact factor: 1.494

9.  Antibiotic resistant Cutibacterium acnes among acne patients in Jordan: a cross sectional study.

Authors:  Eman Alkhawaja; Saleem Hammadi; Medhat Abdelmalek; Naser Mahasneh; Bayan Alkhawaja; Suzanne M Abdelmalek
Journal:  BMC Dermatol       Date:  2020-11-17

10.  Therapeutic Effect of a Newly Isolated Lytic Bacteriophage against Multi-Drug-Resistant Cutibacterium acnes Infection in Mice.

Authors:  Ho Yin Pekkle Lam; Meng-Jiun Lai; Ting-Yu Chen; Wen-Jui Wu; Shih-Yi Peng; Kai-Chih Chang
Journal:  Int J Mol Sci       Date:  2021-06-29       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.